Polymer Factory evaluates move to NGM

The Board of Polymer Factory Sweden AB has decided to evaluate the conditions for listing on Nordic SME on the Nordic Growth Market, Stockholm ("NGM"). The goal is to carry out the list change before the end of Q2, 2024. Existing shareholders should not be affected.

Polymer Factory's share has been listed on Spotlight Stock Market since 2021. The company's Board and management have now started the work required to prepare the company for a change of listing to NGM. The proposed change is intended to be completed before the end of Q2, 2024.

The rationale behind the evaluation includes NGM's cost advantages that are in line with the Company's continuous work to streamline the use of resources.

Existing shareholders in Polymer Factory are not deemed to be affected at all.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.